Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Chunhong He0

Liang Lu0

Liangxing Wu0

Wenqing Yao0

Colin Zhang0

Date of Patent

December 12, 2023

0

Patent Application Number

173370270

Date Filed

June 2, 2021

0

Patent Citations

US Patent 8754114 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

0

US Patent 10450313 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 10611762 Crystalline forms of a FGFR inhibitor and processes for preparing the same

0

US Patent 10632126 Bicyclic heterocycles as FGFR4 inhibitors

0

US Patent 10738048 Bicyclic heterocycles as FGFR4 inhibitors

0

US Patent 10813930 Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

0

US Patent 10851105 Bicyclic heterocycles as FGFR4 inhibitors

0

US Patent 10947230 Bicyclic heterocycles as FGFR inhibitors

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool